Ausgabe Sonderheft 6/2008
Inhalt (22 Artikel)
EDITORIAL
Potentials and limitations of current and emerging immunotherapies
Uwe K. Zettl, Eilhard Mix
Animal models of multiple sclerosis for the development and validation of novel therapies – potential and limitations
Eilhard Mix, Hans Meyer-Rienecker, Uwe K. Zettl
Immunomodulatory treatment strategies in multiple sclerosis
Bernd C. Kieseier, Heinz Wiendl, Verena I. Leussink, Olaf Stüve
Monoclonal antibodies in the therapy of multiple sclerosis
P. S. Rommer, O. Stüve, R. Goertsches, E. Mix, U. K. Zettl
Stem cell transplantation in multiple sclerosis
Sven Schippling, Christoph Heesen, Axel Zander, Roland Martin
α4-Integrin antagonism with natalizumab
Olaf Stüve, Ralf Gold, Andrew Chan, Eilhard Mix, Uwe Zettl, Bernd C. Kieseier
Cerebral MRI lesions and anti-tumor necrosis factor-alpha therapy
Alexander Winkelmann, Robert Patejdl, Sabine Wagner, Reiner Benecke, Uwe Klaus Zettl
Muscle rupture caused by exacerbated spasticity in a patient with multiple sclerosis
Robert Patejdl, Alexander Winkelmann, Reiner Benecke, Uwe Klaus Zettl
Paediatric multiple sclerosis: The experience of the German Centre for Multiple Sclerosis in Childhood and Adolescence
Wiebke Stark*, Peter Huppke*, Jutta Gärtner